儿童性综合征中的亚临床心脏功能障碍:一个病例对照研究
Rajkumar Motiram Meshram1, Somnath M Mohite1, Sagar Chopade1
1Department of Paediatrics and Cardiology, Government Medical College and Super Specialty Hospital, Nagpur, Maharashtra, India.
Heart views : the official journal of the Gulf Heart Association
|October 31, 2025
概括
儿童的性综合征 (NS) 与亚临床心脏功能障碍有关,可通过使用组织多普勒成像 (TDI) 的Tei指数检测到. 较低的血清白蛋白水平与较高的Tei指数相关,表明心血管风险增加.
科学领域:
- 儿童心脏病学 儿童心脏病学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 心血管研究研究心血管研究
背景情况:
- 性综合征 (NS) 增加了由于蛋白尿,炎症和高脂血症的心血管风险.
- 传统的心声回声学在早期检测心脏功能障碍方面存在局限性.
- 用组织多普勒成像 (TDI) 测量的Tei指数是评估亚临床心脏功能障碍的敏感工具.
研究的目的:
- 为了研究患有性综合征的儿童的心脏功能障碍.
- 为了比较NS儿童与健康对照儿童之间的心脏功能.
- 探索心脏功能障碍标志物与NS中的临床/生化参数之间的关系.
主要方法:
- 一项涉及36名患有NS的儿童 (病例) 和36名健康儿童 (对照) 的病例控制研究.
- 数据收集包括人口统计,临床,人体测量,血液学和生物化学参数.
- 进行常规心声学和组织多普勒成像 (TDI) 来测量心脏功能,包括Tei指数.
主要成果:
- 患有NS的儿童的体重指数和心动血压显著提高.
- 这些病例表现出较低的血清白蛋白和较高的总胆固醇,甘油三和LDL胆固醇.
- 虽然常规心声回声扫描显示没有显著差异,但左心室和右心室Tei指数在患有NS的儿童中显著升高 (P < 0.0001).
- 在血清白蛋白和Tei指数之间发现了显著的反相关性.
结论:
- 组织多普勒成像 (TDI) 能够有效地检测到NS儿童的亚临床心脏功能障碍,比传统心声回声更早.
- 在这些患者中,Tei指数与血清白蛋白水平相反相关.
- 早期发现心脏功能障碍对于预防NS儿童心血管疾病进展和心力衰竭至关重要.
相关概念视频
01:24Nephrotic Syndrome I : Introduction
486
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
486
01:26Nephrotic Syndrome II : Assessment and Medical Management
189
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
189
01:24Nephrotic Syndrome III : Nursing Management
276
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
276
01:24Chronic Kidney Disease II: Clinical Manifestations
540
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
540
01:18Chronic Kidney Disease IV: Nursing Management
309
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
309
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
529
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
529